Lavipharm (ATH:LAVI) EV-to-Revenue : 3.08 (As of Sep. 24, 2024)

Lavipharm EV-to-Revenue Chart

Lavipharm Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EV-to-Revenue	Get a 7-Day Free Trial						-	2.13	-	3.09	-

Competitive Comparison of Lavipharm's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Lavipharm's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lavipharm's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lavipharm's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Lavipharm's EV-to-Revenue falls into.

Lavipharm EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Lavipharm's EV-to-Revenue for today is calculated as:

Lavipharm's current Enterprise Value is €158.14 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lavipharm's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was €51.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lavipharm  (ATH:LAVI) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Lavipharm's PS Ratiofor today is calculated as:

Lavipharm's share price for today is €0.804.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2024 was €0.31.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lavipharm EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lavipharm's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Lavipharm Business Description